Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Intra-articular US-guided hypertonic dextrose injection, IA group
Extra-articular US-guided injection targeting MRI-positive lesion sites, EA group.
Locations
1
Taiwan
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan
Start Date
January 23, 2025
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2028
Last Updated
April 24, 2026
NCT07225829
NCT07286747
NCT07254624
NCT07483723
NCT07351968
NCT06747494
Lead Sponsor
Shin Kong Wu Ho-Su Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions